ZY

Zhenfan Yang

DC Dizal (Jiangsu) Pharmaceutical Co.: 6 patents #2 of 36Top 6%
AA Astrazeneca Ab: 3 patents #459 of 1,971Top 25%
Overall (All Time): #401,449 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
11896597 ErbB/BTK inhibitors Xiaolin Zhang 2024-02-13
11629147 Triazolo-pyrimidine compounds and uses thereof Qingbei Zeng, Changhe Qi, Honchung Tsui, Xiaolin Zhang 2023-04-18
11571420 Pyrazine compounds and uses thereof Changhe Qi, Honchung Tsui, Qingbei Zeng, Xiaolin Zhang 2023-02-07
11504375 ErbB/BTK inhibitors Zhengtao LI, Hao ZOU, Wei Zhu, Changmao Shen, Rumin WANG +4 more 2022-11-22
11447492 ERBB receptor inhibitors Zhengtao LI, Wei Zhong, Jiabing Wang, Qingbei Zeng, Honchung Tsui +1 more 2022-09-20
11007198 ErbB/BTK inhibitors Zhengtao LI, Hao ZOU, Wei Zhu, Changmao Shen, Rumin WANG +4 more 2021-05-18
10898481 Pyrazine compounds and uses thereof Changhe Qi, Honchung Tsui, Qingbei Zeng, Xiaolin Zhang 2021-01-26
10858365 Triazolo-pyrimidine compounds and uses thereof Qingbei Zeng, Changhe Qi, Honchung Tsui, Xiaolin Zhang 2020-12-08
10822334 ErbB receptor inhibitors Zhengtao LI, Wei Zhong, Jiabing Wang, Qingbei Zeng, Honchung Tsui +1 more 2020-11-03
9718806 Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor David Yunzhi Li, Jiabing Wang, Qingbei Zeng, Xiaolin Zhang 2017-08-01
9375432 Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor David Yunzhi Li, Jiabing Wang, Qingbei Zeng, Xiaolin Zhang 2016-06-28
9066979 Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor David Yunzhi Li, Jiabing Wang, Qingbei Zeng, Xiaolin Zhang 2015-06-30